comparemela.com

Latest Breaking News On - Sumeet bagadia - Page 5 : comparemela.com

Nifty 50 to Sensex: Why Indian stock market has been rising for last four days — explained with 5 crucial reasons

Stock market today: Positive global sentiments, strong Indian economy, liquidity buzz, and better-than-expected inflation data are driving continuous rallies on Dalal Street

Japan
India
Japanese
Sumeet-bagadia
Indian-psus
Sandeep-pandey
Avinash-gorakshkar
Retail-research-at-motilal-oswal
Bank-nifty
Head-of-research-at-profitmart-securities
Executive-director
Choice-broking

Day trading guide for stock market today: Nine stocks to buy or sell on Thursday

Day trading stocks: Market experts have recommended nine stocks to buy today Axis Bank, IRFC, MRPL, HDFC Life, SJVN, HUDCO, Century Text, Sasken Technologies, and SAIL

Ganesh-dongre
Vaishali-parekh
Motilal-oswal
Sumeet-bagadia
Nagaraj-shetti
Chinmay-barve
Shiju-koothupalakkal
Prabhudas-lilladher
Drumil-vithlani
Bank-nifty-call-put
Senior-technical-research-analyst
Bank-nifty-call-put-options

Day trading guide for stock market today: Nine stocks to buy or sell on Wednesday — 14th February

Day trading stocks: Market experts have recommended nine stocks to buy today Solar Industries, Taj Gvk Hotels & Resorts, DLF, Kotak Bank, Havells, Natco Pharma, Inox Wind Ltd, Suven Pharmaceuticals Ltd and Poonawalla.

India
Prabhudas-lilladher
Sumeet-bagadia
Ganesh-dongre
Mitesh-karwa
Chinmay-barve
Kunal-shah
Natco-pharma
Shiju-koothupalakkal
Bank-nifty
Retail-research
Inox-wind-ltd

Choice Broking's Sumeet Bagadia lists Cipla as top 'Valentine's Day 2024 Pick'; here's why

Sumeet Bagadia of Choice Broking has chosen Cipla as his ‘Valentine s Day 2024 Pick’. Bagadia has recommended a ‘Buy’ on the pharma stock at ₹1,450 and up to ₹1,415 for a target price of ₹1,600 to ₹1,660.

United-states
India
South-africa
America
Umang-vohra
Motilal-oswal
Cipla
Exponential-moving-averages
Relative-strength-index
Choice-broking
View-full-image
Nifty-pharma

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.